B of A Securities analyst Sherif El-Sabbahy reinstates Charah Solns (NYSE:CHRA) with a Underperform.
Analyst Downgrades Aravive: Grapples With Trial Setback, Strategic Alternatives
Monday, Aravive Inc (NASDAQ: ARAV) filed its quarterly 10Q
B of A Securities Reinstates Underperform on Charah Solns
B of A Securities analyst Sherif El-Sabbahy reinstates Charah Solns (NYSE:CHRA) with a Underperform.
Related Posts
These Analysts Revise Their Forecasts On Levi Strauss Following Q4 Results
Levi Strauss & Co (NYSE: LEVI) reported upbeat earnings for its fourth quarter on Thursday.
B of A Securities Maintains Buy on Canadian National Railway, Raises Price Target to $140
B of A Securities analyst Ken Hoexter maintains Canadian National Railway (NYSE:CNI) with a Buy and raises the price target from $131 to $140.
7 Analysts Have This to Say About Goldman Sachs Group
Analysts have provided the following ratings for Goldman Sachs Group (NYSE:GS) within the last quarter: